https://www.marketscreener.com/...-FY2019-Financial-Results-29574276/
Full Year FY19 highlights compared with Full Year FY18:
Revenues were $34.0 million, up 14.5% over $29.7 million in FY18
Gross profit was up 15.1%, or $3.3 million, to $24.9 million, from $21.7 million in FY18
SG&A was $11.8 million, an increase of $2.2 million, or 23.1%, over $9.6 million
Total R&D expenditures were $4.3 million, an increase of $363,000, or 9.2% over $3.9 million
For FY19, $1.8 million was capitalized and $2.5 million was expensed
For FY18, $2.1 million was capitalized and $1.8 million was expensed
Income before taxes increased 4.1% to $10.6 million, an increase of $418,000 over $10.1 million
Net income decreased 3.9% to $8.6 million, a decrease of $351,000 from $8.9 million; FY18 included the one-time second-quarter tax benefit of $1.5 million
Diluted earnings per share decreased 5.0% to $0.48 from $0.50. In FY18, the major change in diluted earnings per share came from the $1.5 million tax adjustment that accounted for an $0.08 increase in diluted earnings per share
Cash was $11.4 million, an increase of $2.0 million, or 21.6%, from $9.4 million at the end of FY18.
4QFY19 highlights compared with 4QFY18:
Revenues increased 20.0% to $8.0 million, an increase of $1.3 million over $6.7 million
Gross profit was up 25.6% to $5.7 million, an increase of $1.2 million over $4.6 million
SG&A was $3.2 million, an increase of 42.6%, or $951,000, over $2.2 million
Total R&D expenditures were $1.0 million, an increase of $89,000, or 9.4%, over $951,000
For 4QFY19, $437,000 was capitalized and $603,000 was expensed
For 4QFY18, $514,000 was capitalized and $437,000 was expensed
Income before taxes increased 7.9% to $2.0 million, an increase of $146,000 over $1.8 million
Net income increased 53.9% to $2.1 million, an increase of $721,000 over $1.3 million
Earnings per fully diluted share increased $0.03 to $0.11 from $0.08
|
|
2
Thread abonnieren
